| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |